John Dumot, DO
Basic profileJohn Dumot is a Gastroenterology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 267 publications with 7,039 citations (h-index 47); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
Sponsor: Case Comprehensive Cancer Center
- Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Sponsor: Case Western Reserve University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- US ENDOSCOPYProgram year20252 payments$4,000
- Phathom Pharmaceuticals, Inc.Program year20251 payment$122
- Aimmune Therapeutics, Inc.Program year20254 payments$85
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
77.4%Proton pump inhibitor35.2%Omeprazole43%Pantoprazole Sodium35%Esomeprazole Magnesium13%Lansoprazole8%Part D<11 patientsAntidiarrheal microorganisms8.6%Creon100%Part D≥26 patients+ 13 more classes in this area
Cardiovascular
10.5%Bile Acid Sequestrant5.2%Colestipol Hcl58%Cholestyramine42%Part D≥13 patientsBeta blocker1.6%Carvedilol100%Part D<11 patients+ 3 more classes in this area
Nervous system
10.3%Tricyclic Antidepressant5%Amitriptyline Hcl100%Part D≥20 patientsGabapentinoids1.9%Gabapentin100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial
The American Journal of Gastroenterology
2020 - Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus
Science Translational Medicine
2018 - Cryotherapy and Radiofrequency Ablation for Eradication of Barrett’s Esophagus with Dysplasia or Intramucosal Cancer
Digestive Diseases and Sciences
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Lloyd Greene, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Ian Neeland, MD
University Hospitals of Cleveland
Charles Rice, MD
The Rockefeller University
Jean-Frederic Colombel, MD
Icahn School of Medicine at Mount Sinai
Edward Loftus, MD
Mayo Clinic Rochester
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”